Sun Pharmaceutical Industries Ltd.

In compliance with the Company’s Code of Conduct for Prevention of Insider Trading, Sun Pharmaceutical Industries has informed that the window for trading in the securities of the Company by Designated Persons of the Company (along with his/her immediate relatives or any person with whom he/she shares a material financial relationship), shall remain closed from Saturday, July 1, 2023 till 48 hours after the declaration of Unaudited Financial Results of the Company for the quarter ending June 30, 2023. The date of the Board Meeting of the Company for declaration of the Unaudited Financial Results of the Company for the quarter ending June 30, 2023 will be intimated in due course. 

The above information is a part of company’s filings submitted to BSE.